These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 28185107)

  • 21. The efficacy of antioxidant therapy against oxidative stress and androgen rise in ethylene glycol induced nephrolithiasis in Wistar rats.
    Naghii MR; Jafari M; Mofid M; Eskandari E; Hedayati M; Khalagie K
    Hum Exp Toxicol; 2015 Jul; 34(7):744-54. PubMed ID: 25392345
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Herbo-Mineral Medicine, Lithom Exhibits Anti-Nephrolithiasis Activity in Rat Model of Hyperoxaluria by Attenuating Calcium Oxalate Crystal Formation and Oxidative Stress.
    Balkrishna A; Sinha S; Manik M; Pandey A; Maity M; Dev R; Varshney A
    Discov Med; 2024 Apr; 36(183):799-815. PubMed ID: 38665028
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ethylene glycol induces hyperoxaluria without metabolic acidosis in rats.
    Green ML; Hatch M; Freel RW
    Am J Physiol Renal Physiol; 2005 Sep; 289(3):F536-43. PubMed ID: 15855660
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A polyherbal formulation attenuates hyperoxaluria-induced oxidative stress and prevents subsequent deposition of calcium oxalate crystals and renal cell injury in rat kidneys.
    Bodakhe KS; Namdeo KP; Patra KC; Machwal L; Pareta SK
    Chin J Nat Med; 2013 Sep; 11(5):466-71. PubMed ID: 24359768
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Study of a rat model for calcium oxalate crystal formation without severe renal damage in selected conditions.
    Yamaguchi S; Wiessner JH; Hasegawa AT; Hung LY; Mandel GS; Mandel NS
    Int J Urol; 2005 Mar; 12(3):290-8. PubMed ID: 15828958
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In female rats, ethylene glycol treatment elevates protein expression of hepatic and renal oxalate transporter sat-1 (Slc26a1) without inducing hyperoxaluria.
    Breljak D; Brzica H; Vrhovac I; Micek V; Karaica D; Ljubojević M; Sekovanić A; Jurasović J; Rašić D; Peraica M; Lovrić M; Schnedler N; Henjakovic M; Wegner W; Burckhardt G; Burckhardt BC; Sabolić I
    Croat Med J; 2015 Oct; 56(5):447-59. PubMed ID: 26526882
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vitamin E attenuates crystal formation in rat kidneys: roles of renal tubular cell death and crystallization inhibitors.
    Huang HS; Chen J; Chen CF; Ma MC
    Kidney Int; 2006 Aug; 70(4):699-710. PubMed ID: 16807540
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lipid peroxidation is not the underlying cause of renal injury in hyperoxaluric rats.
    Green ML; Freel RW; Hatch M
    Kidney Int; 2005 Dec; 68(6):2629-38. PubMed ID: 16316339
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of hydroalcoholic extract of Hypericum perforatum L. leaves on ethylene glycol-induced kidney calculi in rats.
    Khalili M; Jalali MR; Mirzaei-Azandaryani M
    Urol J; 2012; 9(2):472-9. PubMed ID: 22641490
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Changes in the oxidant-antioxidant balance in the kidney of rats with nephrolithiasis induced by ethylene glycol.
    Huang HS; Ma MC; Chen J; Chen CF
    J Urol; 2002 Jun; 167(6):2584-93. PubMed ID: 11992092
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anti-urolithiatic effect of cow urine ark on ethylene glycol-induced renal calculi.
    Shukla AB; Mandavia DR; Barvaliya MJ; Baxi SN; Tripathi CB
    Int Braz J Urol; 2013; 39(4):565-71. PubMed ID: 24054385
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Low-vitamin E diet exacerbates calcium oxalate crystal formation via enhanced oxidative stress in rat hyperoxaluric kidney.
    Huang HS; Ma MC; Chen J
    Am J Physiol Renal Physiol; 2009 Jan; 296(1):F34-45. PubMed ID: 18799548
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preventive effect of specific antioxidant on oxidative renal cell injury associated with renal crystal formation.
    Fishman AI; Green D; Lynch A; Choudhury M; Eshghi M; Konno S
    Urology; 2013 Aug; 82(2):489.e1-7. PubMed ID: 23796398
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The effects of the active constituents of Alisma orientalis on renal stone formation and bikunin expression in rat urolithiasis model].
    Cao ZG; Liu JH; Zhou SW; Wu W; Yin CP; Wu JZ
    Zhonghua Yi Xue Za Zhi; 2004 Aug; 84(15):1276-9. PubMed ID: 15387965
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Amelioration of hyperoxaluria-induced kidney dysfunction by chemical chaperone 4-phenylbutyric acid.
    Randhawa R; Bhardwaj R; Kaur T
    Urolithiasis; 2019 Apr; 47(2):171-179. PubMed ID: 29947992
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of sulphated polysaccharides on erythrocyte changes due to oxidative and nitrosative stress in experimental hyperoxaluria.
    Veena CK; Josephine A; Preetha SP; Varalakshmi P
    Hum Exp Toxicol; 2007 Dec; 26(12):923-32. PubMed ID: 18375635
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A comparative study on several models of experimental renal calcium oxalate stones formation in rats.
    Liu J; Cao Z; Zhang Z; Zhou S; Ye Z
    J Huazhong Univ Sci Technolog Med Sci; 2007 Feb; 27(1):83-7. PubMed ID: 17393118
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Protective role of enalapril for chronic tubulointerstitial lesions of hyperoxaluria.
    Toblli JE; Ferder L; Stella I; Angerosa M; Inserra F
    J Urol; 2001 Jul; 166(1):275-80. PubMed ID: 11435885
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oral L-arginine supplementation ameliorates urinary risk factors and kinetic modulation of Tamm-Horsfall glycoprotein in experimental hyperoxaluric rats.
    Pragasam V; Kalaiselvi P; Sumitra K; Srinivasan S; Varalakshmi P
    Clin Chim Acta; 2005 Oct; 360(1-2):141-50. PubMed ID: 15992786
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The preventive effects of Ulva lactuca aqueous extract, ulvan polysaccharides and atorvastatin on ethylene glycol-induced hyperoxaluria.
    Abdelaziz MA; Ahmed OM; Abdel-Gabbar M; Mohammad MR; Ibrahim SR; Abdelzaher MH; Mohideen AP; Moawd SA; Geddawy AI
    Eur Rev Med Pharmacol Sci; 2023 Apr; 27(8):3699-3713. PubMed ID: 37140319
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.